Insider Trading - Immuneering Corp (IMRX)
Real time insider trading transaction history:
- Insiders must file a Form 4 covering their trades within two business days.
- Section 16 prohibits insiders from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2021-08-03 Purchase | 2021-08-04 06:04 am | Immuneering Corp | IMRX | Amin Biren CFO | 4,175 | $15 | $62,625 | 6,898 (Direct) | View |
| 2021-08-03 Purchase | 2021-08-04 06:04 am | Immuneering Corp | IMRX | Barrett Scott Chief Medical Officer | 667 | $15 | $10,005 | 6,663 (Direct) | View |
| 2021-08-03 Purchase | 2021-08-04 06:04 am | Immuneering Corp | IMRX | BERMAN ANN E Director | 3,500 | $15 | $52,500 | 3,500 (Direct) | View |
| 2021-08-03 Purchase | 2021-08-04 06:05 am | Immuneering Corp | IMRX | Bookman Michael General Counsel and Secretary | 1,402 | $15 | $21,030 | 1,402 (Direct) | View |
| 2021-08-03 Purchase | 2021-08-04 06:05 am | Immuneering Corp | IMRX | CARPENTER ROBERT J Director | 325,000 | $15 | $4,875,000 | 1,148,839 (Direct) | View |
| 2021-08-03 Purchase | 2021-08-04 06:05 am | Immuneering Corp | IMRX | Hall Brett Matthew Chief Scientific Officer | 1,353 | $15 | $20,295 | 6,393 (Direct) | View |
| 2021-08-03 Purchase | 2021-08-04 06:06 am | Immuneering Corp | IMRX | KEATING LAURIE Director | 7,000 | $15 | $105,000 | 7,000 (Direct) | View |
| 2021-08-03 Purchase | 2021-08-04 06:06 am | Immuneering Corp | IMRX | Zeskind Benjamin J. CEO 10% Owner | 2,098 | $15 | $31,470 | 2,600,269 (Indirect Direct) | View |
| 2021-08-03 Purchase | 2021-08-04 06:06 am | Immuneering Corp | IMRX | Feinberg Peter Director | 291,667 | $15 | $4,375,005 | 115,441 (Indirect) | View |
| 2021-08-03 Purchase | 2021-08-05 4:01 pm | Immuneering Corp | IMRX | Cormorant Asset Management LP Chen Bihua Cormorant Global Healthcare Master Fund LP Cormorant Private Healthcare Fund III LP Former 10% Owner | 550,000 | $15 | $8,250,000 | 2,252,628 (Indirect) | View |
| 2021-09-13 Purchase | 2021-09-14 4:47 pm | Immuneering Corp | IMRX | Zeskind Benjamin J. CEO 10% Owner | 2,083 | $22.87 | $47,632 | 2,602,352 (Indirect Direct) | View |
| 2021-09-13 Purchase | 2021-09-15 5:58 pm | Immuneering Corp | IMRX | Feinberg Peter Director | 6,099 | $21.5 | $131,114 | 349 (Indirect Direct) | View |
| 2021-09-20 Purchase | 2021-09-21 5:53 pm | Immuneering Corp | IMRX | Feinberg Peter Director | 4,750 | $24.44 | $116,114 | 5,099 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2021-07-29 Option Award | 2021-07-30 4:27 pm | N/A 2031-07-28 | Immuneering Corp | IMRX | BERMAN ANN E Director | 28,371 | $0 | 28,371 (Direct) | View |
| 2021-07-29 Option Award | 2021-07-30 4:29 pm | N/A 2031-07-28 | Immuneering Corp | IMRX | Bookman Michael General Counsel and Secretary | 101,116 | $0 | 101,116 (Direct) | View |
| 2021-08-03 Conversion | 2021-08-04 06:04 am | N/A N/A | Immuneering Corp | IMRX | Amin Biren CFO | 2,723 | $0 | 2,723 (Direct) | View |
| 2021-08-03 Conversion | 2021-08-04 06:04 am | N/A N/A | Immuneering Corp | IMRX | Amin Biren CFO | 2,723 | $0 | 0 (Direct) | View |
| 2021-08-03 Conversion | 2021-08-04 06:04 am | N/A N/A | Immuneering Corp | IMRX | Barrett Scott Chief Medical Officer | 5,996 | $0 | 5,996 (Direct) | View |
| 2021-08-03 Conversion | 2021-08-04 06:04 am | N/A N/A | Immuneering Corp | IMRX | Barrett Scott Chief Medical Officer | 3,273 | $0 | 0 (Direct) | View |
| 2021-08-03 Conversion | 2021-08-04 06:04 am | N/A N/A | Immuneering Corp | IMRX | Barrett Scott Chief Medical Officer | 2,723 | $0 | 0 (Direct) | View |
| 2021-08-03 Conversion | 2021-08-04 06:05 am | N/A N/A | Immuneering Corp | IMRX | CARPENTER ROBERT J Director | 217,173 | $0 | 823,839 (Direct) | View |
| 2021-08-03 Conversion | 2021-08-04 06:05 am | N/A N/A | Immuneering Corp | IMRX | CARPENTER ROBERT J Director | 94,585 | $0 | 0 (Direct) | View |
| 2021-08-03 Conversion | 2021-08-04 06:05 am | N/A N/A | Immuneering Corp | IMRX | CARPENTER ROBERT J Director | 122,588 | $0 | 0 (Direct) | View |
| 2021-08-03 Conversion | 2021-08-04 06:05 am | N/A N/A | Immuneering Corp | IMRX | Hall Brett Matthew Chief Scientific Officer | 5,040 | $0 | 5,040 (Direct) | View |
| 2021-08-03 Conversion | 2021-08-04 06:05 am | N/A N/A | Immuneering Corp | IMRX | Hall Brett Matthew Chief Scientific Officer | 1,636 | $0 | 0 (Direct) | View |
| 2021-08-03 Conversion | 2021-08-04 06:05 am | N/A N/A | Immuneering Corp | IMRX | Hall Brett Matthew Chief Scientific Officer | 3,404 | $0 | 0 (Direct) | View |
| 2021-08-03 Conversion | 2021-08-04 06:06 am | N/A N/A | Immuneering Corp | IMRX | Zeskind Benjamin J. CEO 10% Owner | 49,099 | $0 | 2,598,171 (Direct) | View |
| 2021-08-03 Conversion | 2021-08-04 06:06 am | N/A N/A | Immuneering Corp | IMRX | Zeskind Benjamin J. CEO 10% Owner | 40,928 | $0 | 0 (Direct) | View |
| 2021-08-03 Conversion | 2021-08-04 06:06 am | N/A N/A | Immuneering Corp | IMRX | Zeskind Benjamin J. CEO 10% Owner | 8,171 | $0 | 0 (Direct) | View |
| 2021-08-03 Conversion | 2021-08-04 06:06 am | N/A N/A | Immuneering Corp | IMRX | Feinberg Peter Director | 133,572 | $0 | 257,325 (Indirect) | View |
| 2021-08-03 Conversion | 2021-08-04 06:06 am | N/A N/A | Immuneering Corp | IMRX | Feinberg Peter Director | 123,155 | $0 | 347,401 (Indirect) | View |
| 2021-08-03 Conversion | 2021-08-04 06:06 am | N/A N/A | Immuneering Corp | IMRX | Feinberg Peter Director | 82,108 | $0 | 82,108 (Indirect) | View |
| 2021-08-03 Conversion | 2021-08-04 06:06 am | N/A N/A | Immuneering Corp | IMRX | Feinberg Peter Director | 102,926 | $0 | 0 (Indirect) | View |
| 2021-08-03 Conversion | 2021-08-04 06:06 am | N/A N/A | Immuneering Corp | IMRX | Feinberg Peter Director | 92,509 | $0 | 0 (Indirect) | View |
| 2021-08-03 Conversion | 2021-08-04 06:06 am | N/A N/A | Immuneering Corp | IMRX | Feinberg Peter Director | 51,462 | $0 | 0 (Indirect) | View |
| 2021-08-03 Conversion | 2021-08-04 06:06 am | N/A N/A | Immuneering Corp | IMRX | Feinberg Peter Director | 30,646 | $0 | 0 (Indirect) | View |
| 2021-08-03 Conversion | 2021-08-04 06:06 am | N/A N/A | Immuneering Corp | IMRX | Feinberg Peter Director | 30,646 | $0 | 0 (Indirect) | View |
| 2021-08-03 Conversion | 2021-08-04 06:06 am | N/A N/A | Immuneering Corp | IMRX | Feinberg Peter Director | 30,646 | $0 | 0 (Indirect) | View |
| 2021-08-03 Conversion | 2021-08-05 4:01 pm | N/A N/A | Immuneering Corp | IMRX | Cormorant Asset Management LP Chen Bihua Cormorant Global Healthcare Master Fund LP Cormorant Private Healthcare Fund III LP Former 10% Owner | 1,702,628 | $0 | 1,702,628 (Indirect) | View |
| 2021-08-03 Conversion | 2021-08-05 4:01 pm | N/A N/A | Immuneering Corp | IMRX | Cormorant Asset Management LP Chen Bihua Cormorant Global Healthcare Master Fund LP Cormorant Private Healthcare Fund III LP Former 10% Owner | 1,702,628 | $0 | 0 (Indirect) | View |